Agenda for the May 2022 PBAC Intracycle meeting
Page last updated: 11 February 2022
The agenda for the May 2022 PBAC Intracycle meeting is now available.
The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration.
The company applying for subsidy under the Pharmaceutical Benefits Scheme has already provided the PBAC with detailed clinical and economic data in support of the application. To provide consultation input, please go to the Office of Health Technology Assessment (OHTA) Consultation Hub and click on the PBAC link.